Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer
Clinical trial NCT04758780 · COMPLETED
Trial details
- NCT number
- NCT04758780
- Sponsor
- Institut Cancerologie de l'Ouest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-21
- Primary completion
- 2023-03-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.